BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 17786438)

  • 1. Tumor hypoxia imaging in orthotopic liver tumors and peritoneal metastasis: a comparative study featuring dynamic 18F-MISO and 124I-IAZG PET in the same study cohort.
    Riedl CC; Brader P; Zanzonico P; Reid V; Woo Y; Wen B; Ling CC; Hricak H; Fong Y; Humm JL
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):39-46. PubMed ID: 17786438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning.
    Zanzonico P; O'Donoghue J; Chapman JD; Schneider R; Cai S; Larson S; Wen B; Chen Y; Finn R; Ruan S; Gerweck L; Humm J; Ling C
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):117-28. PubMed ID: 14523586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model.
    Dubois L; Landuyt W; Cloetens L; Bol A; Bormans G; Haustermans K; Labar D; Nuyts J; Grégoire V; Mortelmans L
    Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):209-18. PubMed ID: 18690432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.
    O'Donoghue JA; Zanzonico P; Pugachev A; Wen B; Smith-Jones P; Cai S; Burnazi E; Finn RD; Burgman P; Ruan S; Lewis JS; Welch MJ; Ling CC; Humm JL
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1493-502. PubMed ID: 15817355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated synthesis and PET evaluation of both enantiomers of [¹⁸F]FMISO.
    Revunov E; Jørgensen JT; Jensen AI; Hansen AE; Severin GW; Kjær A; Zhuravlev F
    Nucl Med Biol; 2015 Apr; 42(4):413-9. PubMed ID: 25595134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of [18F]-FMISO, [18F]-FAZA and [18F]-HX4 for PET imaging of hypoxia--a simulation study.
    Wack LJ; Mönnich D; van Elmpt W; Zegers CM; Troost EG; Zips D; Thorwarth D
    Acta Oncol; 2015; 54(9):1370-7. PubMed ID: 26203928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.
    Piert M; Machulla HJ; Picchio M; Reischl G; Ziegler S; Kumar P; Wester HJ; Beck R; McEwan AJ; Wiebe LI; Schwaiger M
    J Nucl Med; 2005 Jan; 46(1):106-13. PubMed ID: 15632040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging hypoxia in orthotopic rat liver tumors with iodine 124-labeled iodoazomycin galactopyranoside PET.
    Riedl CC; Brader P; Zanzonico PB; Chun YS; Woo Y; Singh P; Carlin S; Wen B; Ling CC; Hricak H; Fong Y
    Radiology; 2008 Aug; 248(2):561-70. PubMed ID: 18641253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic Analysis of Dynamic
    Schwartz J; Grkovski M; Rimner A; Schöder H; Zanzonico PB; Carlin SD; Staton KD; Humm JL; Nehmeh SA
    J Nucl Med; 2017 Jun; 58(6):911-919. PubMed ID: 28232611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.
    Okamoto S; Shiga T; Yasuda K; Ito YM; Magota K; Kasai K; Kuge Y; Shirato H; Tamaki N
    J Nucl Med; 2013 Feb; 54(2):201-7. PubMed ID: 23321456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparative Study of Noninvasive Hypoxia Imaging with 18F-Fluoroerythronitroimidazole and 18F-Fluoromisonidazole PET/CT in Patients with Lung Cancer.
    Wei Y; Zhao W; Huang Y; Yu Q; Zhu S; Wang S; Zhao S; Hu X; Yu J; Yuan S
    PLoS One; 2016; 11(6):e0157606. PubMed ID: 27322586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ¹⁸F-HX4 hypoxia imaging with PET/CT in head and neck cancer: a comparison with ¹⁸F-FMISO.
    Chen L; Zhang Z; Kolb HC; Walsh JC; Zhang J; Guan Y
    Nucl Med Commun; 2012 Oct; 33(10):1096-102. PubMed ID: 22836736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
    Cheng Z; Wei R; Wu C; Qing H; Jiang X; Lu H; Chen S; Li X; Xu G; Ai H
    Nucl Med Commun; 2015 Sep; 36(9):914-21. PubMed ID: 25973694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor models.
    Mahy P; De Bast M; de Groot T; Cheguillaume A; Gillart J; Haustermans K; Labar D; Grégoire V
    Radiother Oncol; 2008 Dec; 89(3):353-60. PubMed ID: 18649964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the hypoxia PET tracers [¹⁸F]HX4, [¹⁸F]FAZA, and [¹⁸F]FMISO in a preclinical tumor model.
    Peeters SG; Zegers CM; Lieuwes NG; van Elmpt W; Eriksson J; van Dongen GA; Dubois L; Lambin P
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):351-9. PubMed ID: 25491505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of [
    Nakata N; Kiriu M; Okumura Y; Zhao S; Nishijima KI; Shiga T; Tamaki N; Kuge Y; Matsumoto H
    Nucl Med Biol; 2019 Mar; 70():39-45. PubMed ID: 30836255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O.
    Bruehlmeier M; Roelcke U; Schubiger PA; Ametamey SM
    J Nucl Med; 2004 Nov; 45(11):1851-9. PubMed ID: 15534054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors.
    Sorger D; Patt M; Kumar P; Wiebe LI; Barthel H; Seese A; Dannenberg C; Tannapfel A; Kluge R; Sabri O
    Nucl Med Biol; 2003 Apr; 30(3):317-26. PubMed ID: 12745023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data.
    Casciari JJ; Graham MM; Rasey JS
    Med Phys; 1995 Jul; 22(7):1127-39. PubMed ID: 7565388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A (99m)Tc-labeled misonidazole analogue: step toward a (99m)Tc-alternative to [18F]fluromisonidazole for detecting tumor hypoxia.
    Mallia MB; Mathur A; Sarma HD; Banerjee S
    Cancer Biother Radiopharm; 2015 Mar; 30(2):79-86. PubMed ID: 25569675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.